FindTrial
Sign In

Podocellular antigen expression and renal function progression in Chinese patients with membranous nephropathy: a cohort study

Podocellular antigen expression and renal function progression in Chinese patients with membranous nephropathy: a cohort study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100047986
Enrollment
Unknown
Registered
2021-06-28
Start date
2021-06-22
Completion date
Unknown
Last updated
2022-03-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Membranous nephropathy

Interventions

case group:Nil

Sponsors

Shenzhen Second People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
14 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1.Renal biopsy diagnosed as membranous nephropathy; 2.Age >=14 years old; 3.Biopsy glomeruli >=8; 4.Expected survival time is more than 1 year.

Exclusion criteria

Exclusion criteria: 1.Patients with baseline eGFR<30ml/min/1.73m2; 2.Follow-up time is less than 12 months; 3.Other situations considered by other clinicians to be unsuitable to participate in this study.

Design outcomes

Primary

MeasureTime frame
Renal biopsy target antigen PLA2R, THSD7A, EXT1/2, NELL-1 expression;—

Countries

China

Contacts

Public ContactWan Qijun

Shenzhen Second People’s Hospital

yiyuan@sina.com+86 13537857368

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026